Personas / Equipo Humano

Marçal Pastor-Anglada

Buscador de publicaciones

Publicaciones

  • Gloeckner-Hofmann K, Guillén-Gómez E, Schmidtgen C, Porstmann R, Ziegler R, Stoss O, Casado FJ, Rüschoff J and Pastor-Anglada M.

    Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.

    ONCOLOGY-BASEL . 70(3): 238-244. Nº de citas: 27

    [doi:10.1159/000094541]

  • Purcet S, Minuesa G, Molina-Arcas M, Erkizia I, Casado FJ, Clotet B, Martinez-Picado J and Pastor-Anglada M.

    3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.

    ANTIVIRAL THERAPY . 11(6): 803-811. Nº de citas: 18

  • Aguayo C, Casado J, González M, Pearson JD, Martín RS, Casanello P, Pastor-Anglada M and Sobrevia L.

    Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.

    Placenta . 26(8-9): 641-653. Nº de citas: 23

    [doi:10.1016/j.placenta.2004.10.006]

  • Rodríguez-Mulero S, Errasti-Murugarren E, Ballarín J, Felipe A, Doucet A, Casado FJ and Pastor-Anglada M.

    Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes.

    KIDNEY INT . 68(2): 665-672. Nº de citas: 37

    [doi:10.1111/j.1523-1755.2005.00444.x]

  • Casanello P, Torres A, Sanhueza F, González M, Farías M, Gallardo V, Pastor-Anglada M, San Martín R and Sobrevia L.

    Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium.

    CIRCULATION RESEARCH . 97(1): 16-24. Nº de citas: 75

    [doi:10.1161/01.RES.0000172568.49367.f8]

  • Pastor-Anglada M, Cano-Soldado P, Molina-Arcas M, Lostao MP, Larráyoz I, Martínez-Picado J and Casado FJ.

    Cell entry and export of nucleoside analogues.

    VIRUS RES . 107(2): 151-164. Nº de citas: 114

    [doi:10.1016/j.virusres.2004.11.005]

  • Aymerich I, Duflot S, Fernández-Veledo S, Guillén-Gómez E, Huber-Ruano I, Casado FJ and Pastor-Anglada M.

    The concentrative nucleoside transporter family (SLC28): new roles beyond salvage?

    BIOCHEMICAL SOCIETY TRANSACTIONS . 33(Pt 1): 216-219. Nº de citas: 17

    [doi:10.1042/BST0330216]

  • Cascalló M, Calbó J, Capellà G, Fillat C, Pastor-Anglada M and Mazo A.

    Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors.

    ONCOLOGY-BASEL . 68(2-3): 179-189. Nº de citas: 19

    [doi:10.1159/000086772]

  • Molina-Arcas M, Marcé S, Villamor N, Huber-Ruano I, Casado FJ, Bellosillo B, Montserrat E, Gil J, Colomer D and Pastor-Anglada M.

    Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.

    Leukemia . 19(1): 64-68. Nº de citas: 59

    [doi:10.1038/sj.leu.2403582]

  • Farré X, Guillén-Gómez E, Sánchez L, Hardisson D, Plaza Y, Lloberas J, Casado FJ, Palacios J and Pastor-Anglada M.

    Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.

    INTERNATIONAL JOURNAL OF CANCER . 112(6): 959-966. Nº de citas: 72

    [doi:10.1002/ijc.20524]